Loading…
Reported covered position: VP of Policy and Government Relations
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
American Rescue Plan Act of 2021
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. PN 124 - Nomination of Chiquita Brooks-LaSure to be Administrator of the Centers for Medicare and Medicaid Services. H.R.1319 - American Rescue Plan Act of 2021 - This bill provides additional relief to address the continued impact of COVID-19 (i.e., coronavirus disease 2019) on the economy, public health, state and local governments, individuals, and businesses.
American Rescue Plan Act of 2021
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ACADEMY OF MANAGED CARE PHARMACY via ACADEMY OF MANAGED CARE PHARMACY
2021 · fourth_quarter · Q4
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. Cures 2.0 - Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
Source: Senate LDA
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. PN 124 - Nomination of Chiquita Brooks-LaSure to be Administrator of the Centers for Medicare and Medicaid Services. H.R.1319 - American Rescue Plan Act of 2021 - This bill provides additional relief to address the continued impact of COVID-19 (i.e., coronavirus disease 2019) on the economy, public health, state and local governments, individuals, and businesses. Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services
To prevent across-the-board direct spending cuts, and for other purposes.
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. PN 124 - Nomination of Chiquita Brooks-LaSure to be Administrator of the Centers for Medicare and Medicaid Services. H.R.1319 - American Rescue Plan Act of 2021 - This bill provides additional relief to address the continued impact of COVID-19 (i.e., coronavirus disease 2019) on the economy, public health, state and local governments, individuals, and businesses.
To prevent across-the-board direct spending cuts, and for other purposes.
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
To prevent across-the-board direct spending cuts, and for other purposes.
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. Cures 2.0 - Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
To prevent across-the-board direct spending cuts, and for other purposes.
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. PN 124 - Nomination of Chiquita Brooks-LaSure to be Administrator of the Centers for Medicare and Medicaid Services. H.R.1319 - American Rescue Plan Act of 2021 - This bill provides additional relief to address the continued impact of COVID-19 (i.e., coronavirus disease 2019) on the economy, public health, state and local governments, individuals, and businesses. Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. Cures 2.0 - Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. PN 124 - Nomination of Chiquita Brooks-LaSure to be Administrator of the Centers for Medicare and Medicaid Services. H.R.1319 - American Rescue Plan Act of 2021 - This bill provides additional relief to address the continued impact of COVID-19 (i.e., coronavirus disease 2019) on the economy, public health, state and local governments, individuals, and businesses. Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
Pharmacy and Medically Underserved Areas Enhancement Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. PN 124 - Nomination of Chiquita Brooks-LaSure to be Administrator of the Centers for Medicare and Medicaid Services. H.R.1319 - American Rescue Plan Act of 2021 - This bill provides additional relief to address the continued impact of COVID-19 (i.e., coronavirus disease 2019) on the economy, public health, state and local governments, individuals, and businesses. Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services
Pharmacy and Medically Underserved Areas Enhancement Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
Pharmacy and Medically Underserved Areas Enhancement Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
Pharmacy and Medically Underserved Areas Enhancement Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
Pharmacy and Medically Underserved Areas Enhancement Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. Cures 2.0 - Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
Pharmacy and Medically Underserved Areas Enhancement Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. Cures 2.0 - Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. PN 124 - Nomination of Chiquita Brooks-LaSure to be Administrator of the Centers for Medicare and Medicaid Services. H.R.1319 - American Rescue Plan Act of 2021 - This bill provides additional relief to address the continued impact of COVID-19 (i.e., coronavirus disease 2019) on the economy, public health, state and local governments, individuals, and businesses. Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services
New Opportunities for Value that Extend Lives Act of 2021
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
New Opportunities for Value that Extend Lives Act of 2021
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
New Opportunities for Value that Extend Lives Act of 2021
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. Cures 2.0 - Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
New Opportunities for Value that Extend Lives Act of 2021
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
Consolidated Appropriations Act, 2021
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139) H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act; H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Lower Costs, More Cures Act of 2019
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Communication and correspondence related to rising costs of drugs under Medicare and Medicaid, electronic prescribing, prior authorization and electronic prior authorization, COVID-19 H.R. 3, Lower Drug Costs Now Act of 2019 S. 2543, Prescription Drug Pricing Act of 2019 H.R. 19, Lower Costs, More Cures Act of 2019
Lower Costs, More Cures Act of 2019
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Communication and correspondence related to rising costs of drugs under Medicare and Medicaid, electronic prescribing, prior authorization and electronic prior authorization, COVID-19 H.R. 3, Lower Drug Costs Now Act of 2019 S. 2543, Prescription Drug Pricing Act of 2019 H.R. 19, Lower Costs, More Cures Act of 2019
Lower Costs, More Cures Act of 2019
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Communication and correspondence related to rising costs of drugs under Medicare and Medicaid, electronic prescribing, prior authorization and electronic prior authorization, COVID-19 H.R. 3, Lower Drug Costs Now Act of 2019 S. 2543, Prescription Drug Pricing Act of 2019 H.R. 19, Lower Costs, More Cures Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Communication and correspondence related to rising costs of drugs under Medicare and Medicaid, electronic prescribing, prior authorization and electronic prior authorization, COVID-19 H.R. 3, Lower Drug Costs Now Act of 2019 S. 2543, Prescription Drug Pricing Act of 2019 H.R. 19, Lower Costs, More Cures Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Communication and correspondence related to rising costs of drugs under Medicare and Medicaid, electronic prescribing, prior authorization and electronic prior authorization, COVID-19 H.R. 3, Lower Drug Costs Now Act of 2019 S. 2543, Prescription Drug Pricing Act of 2019 H.R. 19, Lower Costs, More Cures Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Communication and correspondence related to rising costs of drugs under Medicare and Medicaid, electronic prescribing, prior authorization and electronic prior authorization, COVID-19 H.R. 3, Lower Drug Costs Now Act of 2019 S. 2543, Prescription Drug Pricing Act of 2019 H.R. 19, Lower Costs, More Cures Act of 2019
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139)
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139) H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act; H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139)
Families First Coronavirus Response Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139)
Families First Coronavirus Response Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139) H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act; H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Families First Coronavirus Response Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139)
The Heroes Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139)
The Heroes Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139)
The Heroes Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139) H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act; H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139)
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139) H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act; H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139)
Continuing Appropriations Act, 2021 and Other Extensions Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139) H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act; H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Lower Health Care Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139) H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act; H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Lower Health Care Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Communication and correspondence on lowering health care costs, support to changes in 42 C.F.R., dissemination of materials on pharmaceutical information exchange (including amendment to S. 1895 offered by Senator Burr) and issues related to coronavirus relief.
Lower Health Care Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139)
Lower Health Care Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Communication and correspondence on lowering health care costs, support to changes in 42 C.F.R., dissemination of materials on pharmaceutical information exchange (including amendment to S. 1895 offered by Senator Burr),submit comments to the FDA on the draft importation guidance, and issues related to coronavirus relief.
Lower Health Care Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139)
Prescription Drug Pricing Reduction Act of 2019
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Communication and correspondence related to rising costs of drugs under Medicare and Medicaid, electronic prescribing, prior authorization and electronic prior authorization, COVID-19 H.R. 3, Lower Drug Costs Now Act of 2019 S. 2543, Prescription Drug Pricing Act of 2019 H.R. 19, Lower Costs, More Cures Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Communication and correspondence related to rising costs of drugs under Medicare and Medicaid, electronic prescribing, prior authorization and electronic prior authorization, COVID-19 H.R. 3, Lower Drug Costs Now Act of 2019 S. 2543, Prescription Drug Pricing Act of 2019 H.R. 19, Lower Costs, More Cures Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Communication and correspondence related to rising costs of drugs under Medicare and Medicaid, electronic prescribing, prior authorization and electronic prior authorization, COVID-19 H.R. 3, Lower Drug Costs Now Act of 2019 S. 2543, Prescription Drug Pricing Act of 2019 H.R. 19, Lower Costs, More Cures Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Communication and correspondence on S. 1895, the Lower Health Care Costs Act, support for S. 659, Biologic Patent Transparency Act, support for S. 340/H.R. 965, the CREATES Act, support to changes in 42 C.F.R. Chapter 2, dissemination of materials on pharmaceutical information exchange (including amendment to S. 1895 offered by Senator Burr) and issues related to H.R. 3, Lower Drug Costs Now Act of 2019 and S. 2543 Prescription Drug Pricing Reduction Act of 2019
CREATES Act of 2019
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Communication and correspondence on S. 1895, the Lower Health Care Costs Act, support for S. 659, Biologic Patent Transparency Act, support for S. 340/H.R. 965, the CREATES Act, support to changes in 42 C.F.R. Chapter 2, dissemination of materials on pharmaceutical information exchange (including amendment to S. 1895 offered by Senator Burr) and issues related to H.R. 3, Lower Drug Costs Now Act of 2019 and S. 2543 Prescription Drug Pricing Reduction Act of 2019
Lower Health Care Costs Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Communication and correspondence on S. 1895, the Lower Health Care Costs Act, support for S. 659, Biologic Patent Transparency Act, support for S. 340/H.R. 965, the CREATES Act, support to changes in 42 C.F.R. Chapter 2, dissemination of materials on pharmaceutical information exchange (including amendment to S. 1895 offered by Senator Burr) and issues related to H.R. 3, Lower Drug Costs Now Act of 2019 and S. 2543 Prescription Drug Pricing Reduction Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Communication and correspondence on S. 1895, the Lower Health Care Costs Act, support for S. 659, Biologic Patent Transparency Act, support for S. 340/H.R. 965, the CREATES Act, support to changes in 42 C.F.R. Chapter 2, dissemination of materials on pharmaceutical information exchange (including amendment to S. 1895 offered by Senator Burr) and issues related to H.R. 3, Lower Drug Costs Now Act of 2019 and S. 2543 Prescription Drug Pricing Reduction Act of 2019
A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Communication and correspondence on S. 1895, the Lower Health Care Costs Act, support for S. 659, Biologic Patent Transparency Act, support for S. 340/H.R. 965, the CREATES Act, support to changes in 42 C.F.R. Chapter 2, dissemination of materials on pharmaceutical information exchange (including amendment to S. 1895 offered by Senator Burr) and issues related to H.R. 3, Lower Drug Costs Now Act of 2019 and S. 2543 Prescription Drug Pricing Reduction Act of 2019
Biologic Patent Transparency Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: ACADEMY OF MANAGED CARE PHARMACY
Communication and correspondence on S. 1895, the Lower Health Care Costs Act, support for S. 659, Biologic Patent Transparency Act, support for S. 340/H.R. 965, the CREATES Act, support to changes in 42 C.F.R. Chapter 2, dissemination of materials on pharmaceutical information exchange (including amendment to S. 1895 offered by Senator Burr) and issues related to H.R. 3, Lower Drug Costs Now Act of 2019 and S. 2543 Prescription Drug Pricing Reduction Act of 2019
Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACADEMY OF MANAGED CARE PHARMACY via ACADEMY OF MANAGED CARE PHARMACY
2021 · third_quarter · Q3
Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACADEMY OF MANAGED CARE PHARMACY via ACADEMY OF MANAGED CARE PHARMACY
2021 · second_quarter · Q2
Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. PN 124 - Nomination of Chiquita Brooks-LaSure to be Administrator of the Centers for Medicare and Medicaid Services. H.R.1319 - American Rescue Plan Act of 2021 - This bill provides additional relief to address the continued impact of COVID-19 (i.e., coronavirus disease 2019) on the economy, public health, state and local governments, individuals, and businesses. Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACADEMY OF MANAGED CARE PHARMACY via ACADEMY OF MANAGED CARE PHARMACY
2021 · first_quarter · Q1
We have not lobbied on any specific introduced legislation this quarter. Lobbying contacts have been related to the possible introduction of a bill to codify FDA guidance allowing for the exchange of certain economic and clinical data for a drug or new drug use while the product is under review for approval at FDA.
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. PN 124 - Nomination of Chiquita Brooks-LaSure to be Administrator of the Centers for Medicare and Medicaid Services. H.R.1319 - American Rescue Plan Act of 2021 - This bill provides additional relief to address the continued impact of COVID-19 (i.e., coronavirus disease 2019) on the economy, public health, state and local governments, individuals, and businesses.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACADEMY OF MANAGED CARE PHARMACY via ACADEMY OF MANAGED CARE PHARMACY
2020 · fourth_quarter · Q4
Communication and correspondence related to rising costs of drugs under Medicare and Medicaid, electronic prescribing, prior authorization and electronic prior authorization, COVID-19 H.R. 3, Lower Drug Costs Now Act of 2019 S. 2543, Prescription Drug Pricing Act of 2019 H.R. 19, Lower Costs, More Cures Act of 2019
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139) H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act; H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACADEMY OF MANAGED CARE PHARMACY via ACADEMY OF MANAGED CARE PHARMACY
2020 · third_quarter · Q3
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139)
Communication and correspondence related to rising costs of drugs under Medicare and Medicaid, electronic prescribing, prior authorization and electronic prior authorization, COVID-19 H.R. 3, Lower Drug Costs Now Act of 2019 S. 2543, Prescription Drug Pricing Act of 2019 H.R. 19, Lower Costs, More Cures Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACADEMY OF MANAGED CARE PHARMACY via ACADEMY OF MANAGED CARE PHARMACY
2020 · second_quarter · Q2
Coronavirus impact and response, drug pricing, drug shortages, pre-approval information exchange. S. 1895, Lower Health Care Costs Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) H.R. 6201. Families First Coronavirus Response Act (P.L. 116-127) H.R. 748, CARES Act (P.L. 116-136) H.R. 6800, The Heroes Act H.R., Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139)
Communication and correspondence related to rising costs of drugs under Medicare and Medicaid, electronic prescribing, prior authorization and electronic prior authorization, COVID-19 H.R. 3, Lower Drug Costs Now Act of 2019 S. 2543, Prescription Drug Pricing Act of 2019 H.R. 19, Lower Costs, More Cures Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACADEMY OF MANAGED CARE PHARMACY via ACADEMY OF MANAGED CARE PHARMACY
2020 · first_quarter · 1A
Communication and correspondence on lowering health care costs, support to changes in 42 C.F.R., dissemination of materials on pharmaceutical information exchange (including amendment to S. 1895 offered by Senator Burr),submit comments to the FDA on the draft importation guidance, and issues related to coronavirus relief.
Communication and correspondence related to rising costs of drugs under Medicare and Medicaid, electronic prescribing, prior authorization and electronic prior authorization; submit comments to CMS on the MA and Part Annual Rate Notice, and the ACA NBPP.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADEMY OF MANAGED CARE PHARMACY via ACADEMY OF MANAGED CARE PHARMACY
2020 · first_quarter · Q1
Communication and correspondence related to rising costs of drugs under Medicare and Medicaid, Part D, electronic prescribing, prior authorization and electronic prior authorization.
Communication and correspondence on lowering health care costs, support to changes in 42 C.F.R., dissemination of materials on pharmaceutical information exchange (including amendment to S. 1895 offered by Senator Burr) and issues related to coronavirus relief.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADEMY OF MANAGED CARE PHARMACY via ACADEMY OF MANAGED CARE PHARMACY
2019 · fourth_quarter · Q4
Communication and correspondence related to rising costs of drugs under Medicare and Medicaid, electronic prescribing, prior authorization and electronic prior authorization. Sent Dec. 16th letter to Reps. DeGette and Upton on 21st Century Cures 2.0. Submitted comments to HHS on OIG/revisions to safe harbors under the anti-kickback statute.
Communication and correspondence on S. 1895, the Lower Health Care Costs Act, support for S. 659, Biologic Patent Transparency Act, support for S. 340/H.R. 965, the CREATES Act, support to changes in 42 C.F.R. Chapter 2, dissemination of materials on pharmaceutical information exchange (including amendment to S. 1895 offered by Senator Burr) and issues related to H.R. 3, Lower Drug Costs Now Act of 2019 and S. 2543 Prescription Drug Pricing Reduction Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, SENATE